Global Oral Proteins and Peptides Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI360868
  • May 03, 2019
  • Global
  • 109 pages
  • QY Market Research
                                          

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Oral Proteins and Peptides market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Oral Proteins and Peptides market." Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs. The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics. The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes. The global Oral Proteins and Peptides market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Oral Proteins and Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Proteins and Peptides market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Allergan AstraZeneca Biocon Generex Biotechnology Novo Nordisk Synergy Pharmaceuticals Tarsa Therapeutics Sanofi Hoffmann-La Roche Synthetic Biologics Hovione Novartis Segment by Regions North America Europe China Japan Segment by Type Linaclotide Plecanatide Calcitonin Insulin Octreotide Segment by Application Gastric & Digestive Disorders Bone Diseases Diabetes Hormonal Disorders

Table of Contents

Executive Summary
1 Oral Proteins and Peptides Market Overview
    1.1 Product Overview and Scope of Oral Proteins and Peptides
    1.2 Oral Proteins and Peptides Segment by Type
        1.2.1 Global Oral Proteins and Peptides Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Linaclotide
        1.2.3 Plecanatide
        1.2.4 Calcitonin
        1.2.5 Insulin
        1.2.6 Octreotide
    1.3 Oral Proteins and Peptides Segment by Application
        1.3.1 Oral Proteins and Peptides Consumption Comparison by Application (2014-2025)
        1.3.2 Gastric & Digestive Disorders
        1.3.3 Bone Diseases
        1.3.4 Diabetes
        1.3.5 Hormonal Disorders
    1.4 Global Oral Proteins and Peptides Market by Region
        1.4.1 Global Oral Proteins and Peptides Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Oral Proteins and Peptides Market Size
        1.5.1 Global Oral Proteins and Peptides Revenue (2014-2025)
        1.5.2 Global Oral Proteins and Peptides Production (2014-2025)

2 Global Oral Proteins and Peptides Market Competition by Manufacturers
    2.1 Global Oral Proteins and Peptides Production Market Share by Manufacturers (2014-2019)
    2.2 Global Oral Proteins and Peptides Revenue Share by Manufacturers (2014-2019)
    2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Oral Proteins and Peptides Production Sites, Area Served, Product Types
    2.5 Oral Proteins and Peptides Market Competitive Situation and Trends
        2.5.1 Oral Proteins and Peptides Market Concentration Rate
        2.5.2 Oral Proteins and Peptides Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Oral Proteins and Peptides Production Market Share by Regions
    3.1 Global Oral Proteins and Peptides Production Market Share by Regions
    3.2 Global Oral Proteins and ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form